APC and neoplasm: Alkaloid berberine, which is previously used as an anti-inflammatory drug, has proximately been demonstrated to possess anti-tumor activity by reducing Wnt activity and its mechanism of action may involve inhibition of ß-catenin translocation to the nucleus by enhancing the expression of APC gene and stabilizing the complex of APC-β-catenin.